Foghorn Therapeutics, Inc. (FHTX)
2.08
-0.01
(-0.48%)
USD |
NASDAQ |
Oct 30, 16:00
2.085
0.00 (0.00%)
After-Hours: 20:00
Foghorn Therapeutics 30-Day Average Daily Volume : 1.148M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.148M |
| October 29, 2026 | 1.146M |
| October 28, 2026 | 1.141M |
| October 27, 2026 | 1.137M |
| October 26, 2026 | 1.123M |
| October 23, 2026 | 1.120M |
| October 22, 2026 | 1.113M |
| October 21, 2026 | 1.116M |
| October 20, 2026 | 1.096M |
| October 19, 2026 | 1.085M |
| October 16, 2026 | 1.079M |
| October 15, 2026 | 1.061M |
| October 14, 2026 | 1.081M |
| October 13, 2026 | 1.053M |
| October 12, 2026 | 1.034M |
| October 09, 2026 | 1.027M |
| October 08, 2026 | 1.020M |
| October 07, 2026 | 989753.6 |
| October 06, 2026 | 968982.1 |
| October 05, 2026 | 949589.7 |
| October 02, 2026 | 934542.6 |
| October 01, 2026 | 893875.2 |
| September 30, 2026 | 459126.6 |
| September 29, 2026 | 450258.7 |
| September 28, 2026 | 445613.2 |
| Date | Value |
|---|---|
| September 25, 2026 | 439034.7 |
| September 24, 2026 | 428667.9 |
| September 23, 2026 | 419249.8 |
| September 22, 2026 | 372178.6 |
| September 21, 2026 | 373441.1 |
| September 18, 2026 | 376524.1 |
| September 17, 2026 | 371982.5 |
| September 16, 2026 | 369076.9 |
| September 15, 2026 | 362606.9 |
| September 14, 2026 | 354158.5 |
| September 11, 2026 | 346090.6 |
| September 10, 2026 | 342233.8 |
| September 09, 2026 | 335724.9 |
| September 08, 2026 | 334391.5 |
| September 04, 2026 | 332380.6 |
| September 03, 2026 | 327582.6 |
| September 02, 2026 | 317393.7 |
| September 01, 2026 | 290635.9 |
| August 31, 2026 | 289363.5 |
| August 28, 2026 | 292284.0 |
| August 27, 2026 | 293536.7 |
| August 26, 2026 | 288917.7 |
| August 25, 2026 | 286510.4 |
| August 24, 2026 | 284680.2 |
| August 21, 2026 | 280787.2 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Anavex Life Sciences Corp. | 1.310M |
| Vaxcyte, Inc. | 3.169M |
| Connect Biopharma Holdings Ltd. | 7.018M |
| Caribou Biosciences, Inc. | 4.225M |
| Arrowhead Pharmaceuticals, Inc. | 1.853M |